Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Balslev

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Anticancer Research|June 4, 2021
Targeting the Supply Lines of Cancer - A Possible Strategy for Combating the Disease?Oliver Abrahamsen, Eva Balslev, Estrid Høgdall
Ugeskrift for Laeger|October 24, 2007
[Sentinel lymph node biopsy and breast cancer]Anders Husted Madsen, Eva Balslev, Hanne Galatius
The Journal of Hand Surgery, European Volume|May 6, 2024
Cystic soft tissue tumours of the dorsal aspect of the wrist have two distinct histological subtypesJamila Eriksen, Eva Balslev, Niels Henrik Søe
Breast Cancer Research and Treatment|July 11, 2014
Prognosis of synchronous bilateral breast cancer: a review and meta-analysis of observational studiesMarianne Holm, Anne Tjønneland, Eva Balslev, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 31, 2013
Reliability of histological malignancy grade, ER and HER2 status on core needle biopsy vs surgical specimen in breast cancerHelga D Munch-Petersen, Birgitte B Rasmussen, Eva Balslev
Breast Cancer Research and Treatment|March 26, 2010
High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancerOzcan Met, Eva Balslev, Henrik Flyger, et al.
Acta Oncologica (Stockholm, Sweden)|November 24, 2017
Triple negative breast cancer - prognostic role of immune-related factors: a systematic reviewElisabeth Specht Stovgaard, Dorte Nielsen, Estrid Hogdall, et al.
American Journal of Epidemiology|June 6, 2008
Benign breast disease among first-degree relatives of young breast cancer patientsLisbeth Bertelsen, Lene Mellemkjaer, Eva Balslev, et al.
BMC Cancer|April 18, 2015
A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocolIben Kümler, Eva Balslev, Jan Stenvang, et al.
Acta Oncologica (Stockholm, Sweden)|May 10, 2008
Sentinel node biopsy in breast cancer: five years experience from DenmarkPeer Christiansen, Esbern Friis, Eva Balslev, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Anticancer Research|June 4, 2021
Targeting the Supply Lines of Cancer - A Possible Strategy for Combating the Disease?Oliver Abrahamsen, Eva Balslev, Estrid Høgdall
Ugeskrift for Laeger|October 24, 2007
[Sentinel lymph node biopsy and breast cancer]Anders Husted Madsen, Eva Balslev, Hanne Galatius
The Journal of Hand Surgery, European Volume|May 6, 2024
Cystic soft tissue tumours of the dorsal aspect of the wrist have two distinct histological subtypesJamila Eriksen, Eva Balslev, Niels Henrik Søe
Breast Cancer Research and Treatment|July 11, 2014
Prognosis of synchronous bilateral breast cancer: a review and meta-analysis of observational studiesMarianne Holm, Anne Tjønneland, Eva Balslev, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 31, 2013
Reliability of histological malignancy grade, ER and HER2 status on core needle biopsy vs surgical specimen in breast cancerHelga D Munch-Petersen, Birgitte B Rasmussen, Eva Balslev
Breast Cancer Research and Treatment|March 26, 2010
High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancerOzcan Met, Eva Balslev, Henrik Flyger, et al.
Acta Oncologica (Stockholm, Sweden)|November 24, 2017
Triple negative breast cancer - prognostic role of immune-related factors: a systematic reviewElisabeth Specht Stovgaard, Dorte Nielsen, Estrid Hogdall, et al.
American Journal of Epidemiology|June 6, 2008
Benign breast disease among first-degree relatives of young breast cancer patientsLisbeth Bertelsen, Lene Mellemkjaer, Eva Balslev, et al.
BMC Cancer|April 18, 2015
A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocolIben Kümler, Eva Balslev, Jan Stenvang, et al.
Acta Oncologica (Stockholm, Sweden)|May 10, 2008
Sentinel node biopsy in breast cancer: five years experience from DenmarkPeer Christiansen, Esbern Friis, Eva Balslev, et al.
Pageof 9